test

Troy Wuertz

@Ikarian Capital, Llc

Latest period2024 - Q3ReportedManaged Assets$717.154MTotal holdings121
Assets growth rate24.93%Assets growth rate (2-Q avg)-6.06%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Ikarian Capital, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 121 positions.

Assets under management

The assets under management (AUM) of Ikarian Capital, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 717.154M in assets, with a quarterly growth rate of 24.93% and a 2-quarter average growth rate of -6.06%. The portfolio is managed by Troy Wuertz, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
ANROAlto Neuroscience Inc
Recent Activity
New Position
1.41%
$10.079M↓ Put
881,000 shares@ $11.44 avg price
RAREUltragenyx Pharmaceutical In
Recent Activity
New Position
1.39%
$9.943M
179,000 shares@ $55.55 avg price
AVTXAvalo Therapeutics Inc
Recent Activity
Increased 1673%
1.29%
$9.218M
970,359 shares@ $9.51 avg price
SYRESpyre Therapeutics Inc
Recent Activity
New Position
1.24%
$8.889M
302,247 shares@ $29.42 avg price
BGNEBeigene Ltd
Recent Activity
New Position
1.17%
$8.332M↑ Call
117,967 shares@ $70.63 avg price
CPRXCatalyst Pharmaceuticals Inc
Recent Activity
Decreased -19.39%
1.16%
$8.307M
417,850 shares@ $19.88 avg price
TECXTectonic Therapeutic Inc
Recent Activity
Increased 325.15%
1.13%
$8.094M
267,145 shares@ $30.31 avg price
BPMCBlueprint Medicines Corp
Recent Activity
New Position
1.1%
$7.863M
85,000 shares@ $92.51 avg price
BBIOBridgebio Pharma Inc
Recent Activity
Decreased -15.5%
1.02%
$7.272M
285,613 shares@ $25.46 avg price
BDTXBlack Diamond Therapeutics I
Recent Activity
New Position
1.01%
$7.178M↓ Put
1.65M shares@ $4.35 avg price